标题
Home
About Us
Company Introduction
Team Introduction
Quality System
Contact Us
Process Development
Process Development and Optimization
Analytical Method Development and Validation
Stability studies
Formulation and aseptic filling, lyophilization
Oligo Manufacturing
Preclinical Development, Research-Grade
Clinical Phase I-III Production
Early Commercial Phase
GMP Compliance
GMP Facilities and Equipment
EHS System
Collaborations
Case Study
Other Service
IND Application Dossiers
The Melting Temperature (Tm) Test
Formulation Development and Production
EN
CN
About
Enable Innovative Drug Discover with DEL, FBDD and SBDD
About
About
标题
Application of imiquimod-induced murine psoriasis model in evaluating interleukin-17A antagonist
Release time:2021-01-28
Previous:
Employing Photocatalysis for the Design and Preparation of DNA‐Encoded Libraries: A Case Study
Next:
Selecting Approaches for Hit Identification and Increasing Options by Building the Efficient Discovery of Actionable Chemical Matter from DNA-Encoded Libraries
Home
/
Publications
/
Application of imiquimod-induced murine psoriasis model in evaluating interleukin-17A antagonist